Condition: Chronic Spontaneous Urticaria (CSU) · Hidradenitis Suppurativa (HS) · Psoriasis (PsO) · Sponsor: Leiden University Medical Center
The goal of this observational study is to comprehensively profile six immune-mediated inflammatory diseases, including atopic dermatitis (AD), plaque psoriasis (PSO), hidradenitis suppurativa (HS), cutaneous T-cell lymphoma subtype mycosis fungoides (MF), chronic spontaneous urticaria (CSU), and cutaneous lupus erythematosus (CLE) in daily practice. Data will be compared with data from healthy volunteers. This study is part of the larger NGID (Next Generation ImmunoDermatology) initiative, of which the main objective is to develop infrastructure that enables personalised patient care. The main questions the SKINERGY study aims to answer are: * Which biomarkers can discriminate between responders and non-responders to treatment in patients with AD, CLE, CSU, HS, MF, and PSO? * How do disease-related biomarkers in patients with AD, CLE, CSU, HS, MF, and PSO differ from those in healthy volunteers? * Which (multi-omics) biomarkers are associated with disease subtypes and predict response or non-response to (targeted) therapies in daily clinical practice? * How do biomarker profiles compare across different cohorts of patients with immune-mediated inflammatory skin diseases (AD, CLE, CSU, HS, MF, PSO) * How do biomarker levels change over time in response to treatment in these patient populations? * Which skin tissue biomarkers are associated with disease progression or treatment response? * How do the genomic profiles of patients differ across diseases or correlate with treatm…
This description comes directly from the study's public registry record.
Robert Rissmann, Professor · +31 71 526 9111 · r.rissmann@lumc.nl
Martijn van Doorn, MD, PhD · +31 10 704 0704 · m.b.a.vandoorn@erasmusmc.nl
Always discuss trial participation with your own doctor first.
| Radboud University Medical Center | Nijmegen, Gelderland, Netherlands | Not Yet Recruiting |
| Maastricht University Medical Center+ | Maastricht, Limburg, Netherlands | Not Yet Recruiting |
| Amsterdam University Medical Center | Amsterdam, North Holland, Netherlands | Not Yet Recruiting |
| University Medical Center Groningen | Groningen, Provincie Groningen, Netherlands | Not Yet Recruiting |
| Leiden University Medical Center | Leiden, South Holland, Netherlands | Not Yet Recruiting |
| Centre for Human Drug Research | Leiden, South Holland, Netherlands | Not Yet Recruiting |
| Erasmus Medical Center | Rotterdam, South Holland, Netherlands | Not Yet Recruiting |
| University Medical Center Utrecht | Utrecht, Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07021495